The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index; none of the 162 sources its claims cite is checked for support yet.
Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline
Open accessAbstract
Objectives: To improve awareness and recognition of chronic bacterial prostatitis ( CBP ) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non‐specialists and patients. To provide guidance to healthcare professionals treating patients with CBP and CP / CPPS , in both non‐specialist and specialist settings. To promote efficient referral of care between non‐specialists and specialists and the involvement of the multidisciplinary team ( MDT ). Patients and Methods: The guideline population were men with CBP or CP / CPPS (persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months). Consensus recommendations for the guidelines were based on a search to identify literature on the diagnosis and management of CBP and CP / CPPS (published between 1999 and February 2014). A Delphi panel process was used where high‐quality, published evidence was lacking. Results: CBP and CP / CPPS can present with a wide range of clinical manifestations. The four main symptom domains are urogenital pain, lower urinary tract symptoms ( LUTS – voiding or storage symptoms), psychological issues and sexual dysfunction. Patients should be managed according to their individual symptom pattern. Options for first‐line treatment include antibiotics, α‐adrenergic antagonists (if voiding LUTS are present) and simple analgesics. Repeated use of antibiotics, such as quinolones, should be avoided if there is no obvious symptomatic benefit from infection control or cultures do not support an infectious cause. Early use of treatments targeting neuropathic pain and/or referral to specialist services should be considered for patients who do not respond to initial measures. An MDT approach (urologists, pain specialists, nurse specialists, specialist physiotherapists, general practitioners, cognitive behavioural therapists/psychologists, and sexual health specialists) is recommended. Patients should be fully informed about the possible underlying causes and treatment options, including an explanation of the chronic pain cycle. Conclusion: Chronic prostatitis can present with a wide variety of signs and symptoms. Identification of individual symptom patterns and a symptom‐based treatment approach are recommended. Further research is required to evaluate management options for CBP and CP / CPPS .
Overview
CoChat Summary
TL;DR
This consensus guideline from the Prostatitis Expert Reference Group provides symptom-based diagnosis and management recommendations for chronic bacterial prostatitis (CBP) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). It recommends individualized care across four symptom domains, cautious antibiotic use, early consideration of neuropathic pain treatment/referral, and a multidisciplinary approach.
Key findings
- CBP and CP/CPPS should be managed by individual symptom pattern across four main domains: urogenital pain, lower urinary tract symptoms (LUTS), psychological issues, and sexual dysfunction; no single management pathway suits all patients.
- Reported symptom burdens include perineal pain as the most prevalent pain localization (63%), irritable bowel syndrome in 22–31%, ≥1 LUTS in 39–68%, and in CP/CPPS cohort studies (n = 130–1,800) total/partial erectile dysfunction in 15–55% and overall self-reported sexual dysfunction in 46–92%.
- First-line options include antibiotics, α-adrenergic antagonists if voiding LUTS are present, and simple analgesics; repeated quinolone use should be avoided if there is no obvious symptomatic benefit or cultures do not support infection, and early neuropathic pain treatment/referral plus multidisciplinary team care is recommended for non-responders.
- In CBP, microbiological eradication rates were 40–77% for ciprofloxacin, 75% for levofloxacin, 80% for azithromycin, 77% for doxycycline, 80% for clarithromycin, and 62–77% for azithromycin + ciprofloxacin; most α-blocker RCTs showed positive results, but two larger placebo-controlled trials of tamsulosin (n = 196) and alfuzosin (n = 272) failed to show significant total NIH-CPSI differences.
Methods
- Consensus guideline developed by the Prostatitis Expert Reference Group (PERG); guideline population were men with CBP or CP/CPPS, defined as persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months.
- Literature search on diagnosis and management of CBP and CP/CPPS published between 1999 and 7 February 2014, primarily Medline via PubMed, plus Cochrane Library and guideline groups including NICE and EAU; references graded using Oxford Centre for Evidence-based Medicine Levels of Evidence.
- A web-based Delphi panel process was used where high-quality published evidence was lacking: three questionnaire rounds via Survey Monkey, circulated to 58 participants, with 35 (60%), 29 (50%), and 26 (45%) responding to rounds 1–3; consensus was defined as agreement of ≥70% of respondents, with PERG/technical input where consensus was not achieved.
Limitations
- Paper-stated: there are limited published randomised controlled trials in CBP and CP/CPPS; the Delphi panel was used where high-quality evidence was lacking; many recommendations are Level 5; further research is required; there is no “gold standard” for definitive CP/CPPS diagnosis; evidence is scarce for pain pharmacotherapy, surgical interventions, and CBT/psychotherapy; many studies are small, lack placebo/control arms, or are heterogeneous.
- Evident from the text: this is a consensus guideline rather than a systematic review or meta-analysis, and the Delphi panel had declining response rates (60% to 45%) with a ≥70% respondent consensus threshold, so several recommendations rest on expert opinion.
- Evident from the text: some cited evidence is indirect or limited, such as the REDUCE dutasteride study not being primarily designed as a CP/CPPS treatment trial, and several physiotherapy, acupuncture, phytotherapy, and surgical findings coming from small pilot or proof-of-principle studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
0 Valid · 0 Not valid · 89 Not checked · 29 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The evidence on surgical management techniques such as prostatectomy, transurethral resection of the prostate (TURP), transrectal high‐intensity focused ultrasound (HIFU), transurethral needle ablation (TUNA) of the prostate, and transurethral microwave thermotherapy in CP/CPPS is very limited (Table 5).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While it is recognised that psychosocial symptoms may be part of CBP and CP/CPPS 29, 41, 42, 43, no evidence from RCTs or comparative studies is available to support the use of psychological treatment or CBT in these settings.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Phytotherapy has a modest beneficial effect on symptom improvement in CBP and CP/CPPS and may be considered as a treatment option in treatment‐refractory patients (Level 2).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Several studies of acupuncture have provided positive results (Table 5).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Despite having a significant negative impact on patients' quality of life (QoL) 4 and presenting diagnostic and therapeutic challenges for physicians, CBP and CP/CPPS have received relatively little attention in the literature, in comparison with other urological conditions 2.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Introduction
What the sources say
- Not checked yetcites [2] Pavone‐Macaluso M. Chronic prostatitis syndrome: a common, but poorly understood condition. Part I. EAU‐EBU Update Ser 2007; 5: 1– 15
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
64 more claims
Create a free account to see all 118 claims and to verify the 128 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 35
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Only two RCTs were identified for NSAIDs, one of which evaluated rofecoxib 75 (now withdrawn from the market). The second RCT evaluated celecoxib in patients with CP/CPPS”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“An RCT (n = 50) evaluated ibuprofen vs a terpenic mixture (Rowatinex®) in CP/CPPS; ibuprofen (n = 25) was associated with a significant improvement from baseline in total, pain and QoL NIH‐CPSI scores after 6 weeks' treatment, but was outperformed by the terpene mixture 77.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Most (eight) showed positive results, with significant differences vs placebo in NIH‐CPSI total, urinary symptom, pain, and/or QoL scores 54, 55, 56, 57, 59, 60, or in scores using other validated symptom scoring tools 58, 61.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Notably, two of the larger, placebo‐controlled trials that evaluated tamsulosin (n = 196) 53 and alfuzosin (n = 272) 57 failed to show any significant difference in total NIH‐CPSI scores, the only outcome achieving statistical significance being the score for ejaculation on the Male Sexual Health Questionnaire (P = 0.04) in the alfuzosin trial.”
Citations
Cites
The Delphi Technique: Making Sense of Consensus
Hsu, C.-C., & Sandford, B. A. (2007) · University of Massachusetts Amherst · doi:10.7275/pdz9-th90 · Cited by 4,500
LITWIN, M. S., McNAUGHTON-COLLINS, M., FOWLER, F. J., NICKEL, J. C., CALHOUN, E. A., PONTARI, M. A., ALEXANDER, R. B., FARRAR, J. T., & O'LEARY, M. P. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68562-x · Cited by 947
Guidelines on Urological Infections
Grabe, M. J., Bartoletti, R., Cai, T., Köves, B., Peter Tenke, A., Wagenlehner, F., & Wullt, B. (2009) · Cited by 759
Shoskes, D. A., Zeitlin, S. I., Shahed, A., & Rajfer, J. (1999) · Urology · doi:10.1016/s0090-4295(99)00358-1 · Cited by 408
Krieger, J. N., Lee, S. W. H., Jeon, J., Cheah, P. Y., Liong, M. L., & Riley, D. E. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.028 · Cited by 389
the Chronic Prostatitis Collaborative Research Network, McNaughton Collins, M., Pontari, M. A., O’Leary, M. P., Calhoun, E. A., Santanna, J., Landis, J. R., Kusek, J. W., & Litwin, M. S. (2001) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2001.01223.x · Cited by 281
Anothaisintawee, T. (2011) · JAMA · doi:10.1001/jama.2010.1913 · Cited by 278
Alexander, R. B., Propert, K. J., Schaeffer, A. J., Landis, J. R., Nickel, J. C., O'Leary, M. P., Pontari, M. A., McNaughton-Collins, M., Shoskes, D. A., Comiter, C. V., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-8-200410190-00005 · Cited by 262
ANDERSON, R. U., WISE, D., SAWYER, T., & CHAN, C. (2005) · Journal of Urology · doi:10.1097/01.ju.0000161609.31185.d5 · Cited by 210
Nickel, J. C., Downey, J., Clark, J. M., Casey, R. W., Pommerville, P. J., Barkin, J., Steinhoff, G., Brock, G. B., Patrick, A., Flax, S., et al. (2003) · Urology · doi:10.1016/s0090-4295(03)00583-1 · Cited by 206
Research works printed but not linked: 2
- Nyberg LM, 1999, Textbook of Prostatitis, 28
- University of Oxford Centre for Evidence Based Medicine.OCEBM Levels of Evidence System. Available at:http://www.cebm.net/index.aspx?o=5653. Accessed June 2014
Cited by
Items 101–200 of 369
Han, C., Deng, Y., Hu, P., Hu, B., Wang, T., Liu, J., & Li, M. (2023) · Asian Journal of Andrology · doi:10.4103/aja202336 · Cited by 14
Park, J. S., Jin, M. H., & Hong, C. H. (2018) · International Neurourology Journal · doi:10.5213/inj.1836124.062 · Cited by 14
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
Franco, J. V. A., Tirapegui, F. I., Turk, T., Garrote, V., & Vietto, V. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012551 · Cited by 14
Lao, Y., Li, Z., Bai, Y., Li, W., Wang, J., Wang, Y., Li, Q., & Dong, Z. (2023) · Pain Research and Management · doi:10.1155/2023/2061632 · Cited by 13
CaMK4: Structure, physiological functions, and therapeutic potential
Xu, H., Liang, Y., Gao, X., Chen, Y., Wang, Y., Wang, F., & Hou, X. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116204 · Cited by 13
Wu, Z., Liu, C., Peng, Y., Zhou, F., Xu, B., Zhang, Y., Hu, Z., & Lu, M. (2024) · Translational Andrology and Urology · doi:10.21037/tau-23-386 · Cited by 13
Liu, S., Deng, Y.-J., Yin, Z., Zhao, M. H., Guo, J., & Gao, Q.-H. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3467-1 · Cited by 13
Li, A. S.-W., Niekerk, L. M. V., Wong, A. L. Y., Matthewson, M. L., & Garry, M. I. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2022-0049 · Cited by 13
Glycosylation products in prostate diseases
Silva, P. M. D. S., de Albuquerque, P. B. S., de Oliveira, W. F., Coelho, L. C. B. B., & Correia, M. T. D. S. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.08.003 · Cited by 13
Zhihao, L. I., Wenjun, H., Xiuling, S., Li, Y., & Yuelai, C. (2023) · PubMed Central · doi:10.19852/j.cnki.jtcm.20230608.001 · Cited by 12
Qin, Z., Zang, Z., Wu, J., Zhou, J. W., & Liu, Z. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1428-y · Cited by 12
Wang, J., Yang, J., Deng, S., Yu, X., Bao, B., Liu, R., & Li, H. (2020) · Medicine · doi:10.1097/md.0000000000019540 · Cited by 12
Cui, X., Naveed, M., Baig, M. M. F. A., Wang, W., Mikrani, R., Liu, Z., Ahmad, S. B., Tang, M. Y., Wazir, J., Zhou, X., et al. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13325 · Cited by 12
Li, H., Hung, A., & Yang, A. W. H. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/1612948 · Cited by 12
Li, H., Hung, A., & Yang, A. W. H. (2019) · Integrative Medicine Research · doi:10.1016/j.imr.2019.08.006 · Cited by 12
Lao, Y., He, L., Zhang, P., & Dong, Z. (2022) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2022.06.047 · Cited by 11
Yang, J., Zhang, Q., Zhang, J., Wang, Y., Zhu, G., Song, N., Wang, Z., Chen, J., & Xia, J. (2020) · Andrology · doi:10.1111/andr.12879 · Cited by 11
Biopsychosocial approach to male chronic pelvic pain syndrome: recent treatments and trials
Sandler, M. D., Ledesma, B. R., Thomas, J., Ben-Ezra, L., Lokeshwar, S. D., Paz, L. A., White, J. T., Ramasamy, R., & Masterson, T. A. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qead038 · Cited by 11
Labetov, I. A., Vaganova, A. N., Ковалев, Г. В., & Shkarupa, D. (2024) · Neurourology and Urodynamics · doi:10.1002/nau.25524 · Cited by 11
Postorgasmic Illness Syndrome: What do we know so far?
Hellstrom, W. J. G. (2018) · Journal of Rare Diseases Research & Treatment · doi:10.29245/2572-9411/2018/2.1152 · Cited by 11
Impaired Semen Quality in Patients with Chronic Prostatitis
Rosellen, J., Dittmar, F., Hauptmann, A., Thorsten Diemer, A., Schuppe, H.-C., Schagdarsurengin, U., Fritzenwanker, M., Wagenlehner, F., & Pilatz, A. M. E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102884 · Cited by 10
Hur, K. J., Bae, W. J., Ha, U., Kim, S.-M., Piao, J. J., Jeon, K., Cheon, C. W., Kang, D. U., Lee, J. W., Shin, D., et al. (2024) · Prostate International · doi:10.1016/j.prnil.2024.06.003 · Cited by 10
The role of microbiota in the chronic prostatitis/chronic pelvis pain syndrome: a review
Deng, A.-Q., Yue, S.-Y., Niu, D., Zhang, D.-D., Hou, B., Zhang, L., Liang, C.-Z., & Du, H. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1488732 · Cited by 10
Qin, P., Cao, X., Ni, H., Liu, Y., Tong, Y., Dang, M., & Xu, J. (2025) · Journal of Pain Research · doi:10.2147/jpr.s530646 · Cited by 10
Mechanism progress of acupuncture and moxibustion for chronic prostatitis
Zhi-hao, L. I., Hu, J., Xu, L. I., & Chen, Y. (2021) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2021.08.004 · Cited by 10
Clinical Evaluation of Urine Prostatic Exosomal Protein in the Diagnosis of Chronic Prostatitis
Li, X., Jiang, T., Liu, F., Shao, X., Xu, Y., Sheng, W., & Sun, W. (2017) · Urologia Internationalis · doi:10.1159/000479188 · Cited by 10
Macchione, N., Bernardini, P., Piacentini, I., Mangiarotti, B., & del Nero, A. (2018) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523018666181128164252 · Cited by 10
Li, C., Xu, L., Lin, X., Li, Q., Ye, P., Wu, L., Wang, M., Li, L., Li, L., Zhang, Y., et al. (2021) · Medicine · doi:10.1097/md.0000000000028163 · Cited by 10
Majzoub, A. A., Mahdi, M., Khalil, I. A., Saeedi, A. A., & Al‐Rumaihi, K. (2022) · Urology · doi:10.1016/j.urology.2022.04.028 · Cited by 9
Vocca, C., Abrego-Guandique, D. M., Cione, E., Rania, V., Marcianò, G., Palleria, C., Catarisano, L., Colosimo, M., Cava, G. L., Palumbo, I. M., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13010130 · Cited by 9
Sertraline Alleviates Chronic Prostatitis by Regulating the TRPV1 Channel
Lao, Y., Bai, Y., Guan, X., Wang, J., Wang, Y., Li, R., Ding, Y., & Dong, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s458132 · Cited by 9
Diagnostics of chronic nonbacterial prostatitis
Kadyrov, Z. A., Stepanov, V. S., Ramishvili, S. V., & Mashaneishvili, S. G. (2019) · Andrology and Genital Surgery · doi:10.17650/2070-9781-2019-20-3-36-42 · Cited by 9
Research progress on gels-based nanocomposites in the diagnostics and therapy of prostate diseases
Zhong, R., Chu, R., Zhu, J., Ling, J., Zhang, L., Zhou, Y., Yin, M., Hao, Z., Liang, C. Y., Cao, S., et al. (2023) · Materials Today Sustainability · doi:10.1016/j.mtsust.2023.100323 · Cited by 9
Bozzini, G., Provenzano, M., Buffi, N. M., Seveso, M., Giovanni Lughezzani, A., Guazzoni, G. F., Mandressi, A., & Taverna, G. (2016) · BMC Urology · doi:10.1186/s12894-016-0144-8 · Cited by 9
Wang, X., Zhu, L., Yang, M. H., Chen, Y., & Liu, Z. (2024) · World Journal of Urology · doi:10.1007/s00345-024-04791-y · Cited by 8
Anti-Inflammatory Activity Of Adenoprosin In Nonbacterial Prostatitis
Dumbraveanu, I., & Tanase, A. (2017) · The Moldovan Medical Journal · doi:10.5281/zenodo.1105100 · Cited by 8
Zhang, S., Xie, X., yu, L., Jiang, N., Wei, X., & Hu, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4560609 · Cited by 8
Lee, G. H., & Lee, J. H. (2017) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000668 · Cited by 8
How urologists deal with chronic prostatitis? The preliminary results of a Mediterranean survey
Stamatiou, K. N., Magri, V., Perletti, G., Samara, E., Christopoulos, G., & Trinchieri, A. (2020) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2020.4.353 · Cited by 8
Qin, Z., Liu, Y., Zhou, K., Wu, J., Pang, R., Li, N., Xu, C., Kwong, J. S. W., & Liu, Z. (2017) · Trials · doi:10.1186/s13063-017-2383-8 · Cited by 8
Hydrogel technologies in andrology: advances in research and prospective applications
Guo, X., Zhang, J., Guan, Y., Tian, X., Gong, Y., Xiao, Y., Yang, F., Chang, D., & Yu, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1635007 · Cited by 7
Yang, J., Luan, J., Chen, J., Zhang, Q., Xue, J., Wang, Y., Zhu, G., Song, N., Wang, Z., & Xia, J. (2021) · Asian Journal of Andrology · doi:10.4103/aja202142 · Cited by 7
Acute and Chronic Infectious Prostatitis in Older Adults
Brehm, T. J., Trautner, B. W., & Kulkarni, P. A. (2023) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.09.006 · Cited by 7
Guan, X., Lao, Y., Wang, J., Wang, Y., Bai, Y., Li, X., Liu, S., Li, Z., Li, F., & Dong, Z. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-023-02095-0 · Cited by 7
Morgia, G., Giudice, A. L., Carrino, M., Voce, S., Cocci, A., Reale, G., Minervini, A., Cimino, S., Russo, G. I., & Zingone, F. (2024) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2024.12582 · Cited by 7
Lee, D. H., & Yu, Y. D. (2024) · Korean journal of urology · doi:10.4111/icu.20240191 · Cited by 7
Li, G., Chang, D., Chen, D., Zhang, P., You, Y., Huang, X., Cai, J., & Yang, X. (2020) · Medicine · doi:10.1097/md.0000000000022981 · Cited by 7
Physiotherapeutic assessment and management of chronic pelvic pain syndrome: A case report
Burzyński, B., Jurys, T., Burzyński, K., Cempa, K., & Paradysz, A. (2021) · Medicine · doi:10.1097/md.0000000000025525 · Cited by 7
Reichmann, G., Parlier‐Ahmad, A. B., Beck, L., Thakkar, B., Alappattu, M. J., Boissoneault, J., & Martin, C. E. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2021.787559 · Cited by 7
Li, Z., Liu, J., Liu, P., Zhang, Y., & Han, W. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/6866000 · Cited by 7
RetractedLi, A. S.-W., Wong, A. L. Y., Matthewson, M. L., Niekerk, L. M. V., & Garry, M. I. (2023) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2022-0160 · Cited by 7
Huang, N., Qin, Z., Sun, W., Bao, K., Zha, J., Zhang, P., Feng, P., Zhao, X., Liu, M., Shi, J., et al. (2023) · Trials · doi:10.1186/s13063-023-07633-1 · Cited by 7
Manthey, M., Dansranjav, T., Yan, H., Pilatz, A. M. E., Schuppe, H.-C., Rosellen, J., Krämer, H. H., Neumann, E., Wagenlehner, F., & Schagdarsurengin, U. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105536 · Cited by 6
Hu, J., Xiao, Y., Jiang, G., & Hu, X. (2023) · Journal of Pain Research · doi:10.2147/jpr.s434333 · Cited by 6
Zhou, J. W., Liu, Y., Li, C., & Liu, Z. (2018) · Medicine · doi:10.1097/md.0000000000012887 · Cited by 6
Lv, K., Sun, W.-G., Zhang, T., Zheng, T., Nan, Y.-H., Liu, Y.-F., Zhou, Y.-F., & Wang, R. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.1031739 · Cited by 6
Moore, J. R., Pathak, R. A., Snowden, C., Bolan, C. W., YOUNG, P. R., & Broderick, G. A. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2017.10.02 · Cited by 6
Ramsden, S., Isotta-Day, H., & Horner, P. (2018) · Medicine · doi:10.1016/j.mpmed.2018.03.007 · Cited by 6
López, Y. M. S., Restrepo, V., Maya, W. D. C., & Suárez, J. P. (2024) · Revista Internacional de Andrología · doi:10.22514/j.androl.2024.006 · Cited by 5
Gu, Q., Luan, J., Yu, M., Xia, J., & Wang, Z. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00965-9 · Cited by 5
Balgis, & Wiyono, N. (2024) · Medical Acupuncture · doi:10.1089/acu.2023.0083 · Cited by 5
Qu, G., Jiang, W., Long, Z., Zhou, X., Wang, Y., Yang, G., Tang, C., & Xu, Y. (2024) · Mammalian Genome · doi:10.1007/s00335-024-10044-5 · Cited by 5
Allen, S. M. (2020) · International Journal of Quality Innovation · doi:10.1186/s40887-020-00035-0 · Cited by 5
Efficacy and Safety of Drug Combinations for Chronic Pelvic Pain: Protocol for a Systematic Review
Mohiuddin, M., Park, R., Wesselmann, U., Pukall, C. F., Jarvi, K. A., Nickel, C., Doiron, R. C., & Gilron, I. (2021) · JMIR Research Protocols · doi:10.2196/21909 · Cited by 5
Barannikov, I. I., Kuzmenko, A. V., Gyaurgiev, T. A., & Кузьменко, В. В. (2021) · Urology reports (St - Petersburg) · doi:10.17816/uroved56773 · Cited by 5
Prostatitis: revisión de una patología enigmática y su relación con la fertilidad masculina
Suárez, J. P., & Maya, W. D. C. (2018) · Revista Urología Colombiana / Colombian Urology Journal · doi:10.1055/s-0038-1656520 · Cited by 5
Correction of chronic prostatitis by extracorporeal shock wave therapy
Епифанова, М. В., Kostin, A. A., Gameeva, E. V., Artemenko, S., & Epifanov, А. А. (2022) · Andrology and Genital Surgery · doi:10.17650/1726-9784-2022-23-1-53-59 · Cited by 5
Li, D., Lao, Y., Guan, X., Kong, X., & Dong, Z. (2026) · Medicine · doi:10.1097/md.0000000000047125 · Cited by 4
MODERN PHYSICAL METHODS OF TREATMENT OF PATIENTS WITH CHRONIC NONBACTERIAL PROSTATITIS
Kryanga, A. A. (2019) · Современные проблемы науки и образования · doi:10.17513/spno.28572 · Cited by 4
Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Doiron, R. C., & Nickel, J. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-28599-9_17 · Cited by 4
A case of chronic bacterial prostatitis due toMycoplasma genitalium
Rossotti, R., Travi, G., Bana, N. B., Orcese, C., & Puoti, M. (2023) · Sexually Transmitted Infections · doi:10.1136/sextrans-2023-055935 · Cited by 4
«Schools for Patients» with Urolithiasis and Prostatic Diseases
Gadjiev, N. K., Gorelov, D. S., Akopyan, G. N., Gelig, V. A., Ivanov, A. O., Петров, С. Б., Kryukova, N., Рева, С. А., Ponomareva, Y. A., Al-Shukri, A. S., et al. (2020) · Urology Herald · doi:10.21886/2308-6424-2020-8-1-110-120 · Cited by 4
Acupuncture for chronic prostatitis: A randomized controlled trial
Xie, Z., Deng, Z.-C., Xiao, D., Shi, W., Zhong, F., Tang, Y., Fang, C., Wang, X., Ke, C., & Zhang, W. (2021) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2021.11.006 · Cited by 4
The efficacy of Adenoprosin® in combined treatment of patients with chronic bacterial prostatitis
Medvedev, V. L., & Ефремов, М. Е. (2020) · Innovative medicine of Kuban · doi:10.35401/2500-0268-2020-19-3-45-51 · Cited by 4
Treatment of chronic bacterial prostatitis
Perletti, G., Wagenlehner, F., Škerk, & Magrì (2018) · doi:10.5680/lhuii000035 · Cited by 4
Crofts, M., Blee, K., Evans, C., Tipple, C., Rayment, M., & Horner, P. J. (2026) · International Journal of STD & AIDS · doi:10.1177/09564624261430584 · Cited by 3
Wang, Z., Wu, J., Deng, C., Hu, Y., Shi, S., Liu, S., Huang, X., & Chen, J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1579484 · Cited by 3
Smith, M. A., Knecht, T. P. E., Irwin, M. N., Marshall, V. D., Henry, N. L., & Farris, K. B. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105490 · Cited by 3
Kravchick, S., Shulman, D., Fitzgerald, J. G., Moldwin, R., Kavoussi, L. R., Parekattil, S. J., & Bratslavsky, G. (2025) · Current Urology · doi:10.1097/cu9.0000000000000320 · Cited by 3
A Chinese expert consensus on prostate-pelvic syndrome
Andrology and Sexual Medicine Branch of Chinese Medical Doctors Association, Chinese Association of Andrology, & Chinese Collaborative Group on Diagnosis and Efficacy Evaluation Standards for Chronic Prostatitis (2026) · Current Urology · doi:10.1097/cu9.0000000000000319 · Cited by 3
Horner, P., Crofts, M., & Butterly, J. (2023) · Sexually Transmitted Infections · doi:10.1136/sextrans-2023-056016 · Cited by 3
Li, H., Yang, Y., Shi, M., Xu, L., Huang, Y., Hu, Z., & Qin, G. (2024) · Medicine · doi:10.1097/md.0000000000039558 · Cited by 3
Asymptomatic Leukocytospermia and Assisted Reproductive Technology Outcomes: Reason for concern?
Reich, M.-C., Heide, N., Humaidan, P., & Esteves, S. C. (2025) · International braz j urol · doi:10.1590/s1677-5538.ibju.2025.0166 · Cited by 3
Interventions for treating chronic prostatitis/chronic pelvic pain syndrome
Franco, J. V. A., Tirapegui, F. I., Garrote, V., & Vietto, V. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012320 · Cited by 3
Liu, Y., Huang, L., Zhang, Z., Zhu, Q., Xi, P., Sun, T., & Gong, B. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073331381240923080152 · Cited by 3
Smothers, A., Young, S. W., & Constantine, L. (2020) · Journal of Christian Nursing · doi:10.1097/cnj.0000000000000745 · Cited by 3
Crofts, M., Ramsden, S., & Horner, P. (2022) · Medicine · doi:10.1016/j.mpmed.2022.02.007 · Cited by 3
Wang, S., Qin, P., Zhang, F., & Liu, J. (2022) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2022.06.013 · Cited by 3
Labetov, I. A., Ковалев, Г. В., Волкова, О. В., Shulgin, A. S., & Shkarupa, D. (2022) · Urology Herald · doi:10.21886/2308-6424-2022-10-3-28-35 · Cited by 3
Development and internal validation of a screening tool for chronic prostatitis (S-CP)
Tohi, Y., Hijikata, Y., Sugimoto, M., Kuroda, H., Takei, M., Matsuki, T., Kamitani, T., Kakehi, Y., Fukuhara, S., & Yamamoto, Y. (2023) · World Journal of Urology · doi:10.1007/s00345-023-04574-x · Cited by 3
Deng, L., Zhang, X., Zhu, W., Lu, T., Chen, J., Zou, Q., Zheng, Q., Chen, J., Jiang, C., & Jin, G. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/7312938 · Cited by 3
Nonhormonal Medical Treatment of Male Infertility
Calogero, A. E., Condorelli, R. A., & Vignera, S. L. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_37-1 · Cited by 3
Medical Utilization and Antibiotics Use of Prostatitis Patients in Korea
Lee, B., Choi, Y. J., Choi, Y., Kong, N., & Choi, M.-S. (2018) · Korean Journal of Clinical Pharmacy · doi:10.24304/kjcp.2018.28.2.117 · Cited by 3
Evaluation of chronic prostatitis/chronic pelvic pain syndrome
Magistro, G., & Nickel, J. C. (2019) · doi:10.5680/lhuii000014 · Cited by 3
Cao, Q., Zhou, X., Chen, J., Zhong, Y., Zhang, H., Ao, Q., Liu, M., Nie, H., Zhu, W., & Fu, Y. (2019) · Medicine · doi:10.1097/md.0000000000015678 · Cited by 3
Modern approaches to the treatment of chronic bacterial prostatitis.
Katibov, M. I., Makhachkala, R., & Alibekov, M. M. (2022) · Experimental and Сlinical Urology · doi:10.29188/2222-8543-2022-15-2-130-139 · Cited by 3
Prokar Dasgupta, A., Millar, S., & Wixon, J. (2015) · British Journal of Urology · doi:10.1111/bju.13357 · Cited by 3
Cashman, S., & Biers, S. (2018) · Journal of Clinical Urology · doi:10.1177/2051415816686790 · Cited by 2
Horner, P. J., Connor, E., Williams, S., Butterly, J., & Crofts, M. (2024) · Sexually Transmitted Infections · doi:10.1136/sextrans-2023-055827 · Cited by 2
Zinc Ameliorates Inflammation and Sperm Parameters in Rats With Experimental Autoimmune Prostatitis
Chen, Z., Ma, J., Yu, X., Liu, X., Wang, S., & Wang, Z. (2025) · The Prostate · doi:10.1002/pros.70067 · Cited by 2
Metadata
- Authors
- Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG)
- Affiliations
- Backwell and Nailsea Medical Group Bristol UK
- Addenbrooke's Hospital (GB)
- Prostate Cancer UK (GB)
- Corresponding author
- Rees, Jon
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2015-06-16
- Volume
- 116
- Issue
- 4
- Pages
- 509-525
- ISSN
- 1464-4096 (ISSN-L)
- 1464-410X
- PMC
- PMC5008168
- OpenAlex
- W1997393900
- Semantic Scholar
- 09427e0cfa20489b48a373972c9f66172cfd9cf1
- Cited by
- 371
- References
- 113
- Citations by year
- 2026: 35 · 2025: 34 · 2024: 50 · 2023: 50 · 2022: 32 · 2021: 35 · 2020: 28 · 2019: 31 · 2018: 31 · 2017: 20 · 2016: 18 · 2015: 7
- FWCI
- 21.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- British Journal of Urology (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- Funders
- Prostate Cancer UK
- Topics
- Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Keywords
- chronic bacterial prostatitis, chronic prostatitis/chronic pelvic pain syndrome, diagnosis, treatment, multidisciplinary team, lower urinary tract symptoms, urogenital pain, sexual dysfunction, neuropathic pain, alpha-blockers, antibiotics, quinolones, patient information, specialist referral
- MeSH terms
- Humans, Male, Prostatitis, Pelvic Pain, Consensus, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.